ArticleThoracic cancer2019
Psf3 as a possible biomarker of postoperative chemotherapy for patients with early pulmonary adenocarcinoma.
Kenji Kimura et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it